exercise
Overview
Exercise is a form of planned, structured, and repetitive physical activity performed to improve or maintain physical fitness, health, and functional capacity. In biomedical research, exercise is studied as a modifiable lifestyle intervention rather than as a drug target in the conventional sense. It is widely investigated for its effects on cardiometabolic health, immune function, cancer outcomes, cognitive function, and healthy aging.
Mechanistically, exercise influences multiple physiological systems, including cardiovascular regulation, glucose metabolism, body composition, skeletal muscle function, inflammatory signaling, and immune surveillance. Recent research contexts also link exercise with autophagy, depression-cancer interactions, and rehabilitation after major illness or surgery. Across these settings, exercise is commonly evaluated as a safe, low-cost, non-pharmacological strategy that may complement therapies such as diet modification, intermittent fasting, ketogenic diet, and oncological rehabilitation protocols.
Recent Publications Summary
Recent publications have focused on exercise as a therapeutic and preventive intervention across neurological, oncological, cardiometabolic, and healthy-aging contexts. In Parkinson’s disease, a Bayesian dose-response network meta-analysis of 25 randomized controlled trials found that exercise was associated with a significant non-linear reduction in depressive symptoms in middle-aged and older adults, with benefits sustained between 110 and 890 met-minutes per week and peaking at 560 met-minutes per week; the authors identified an optimal range of 440-670 met-minutes per week and reported that effects were not stable at 1000 met-minutes per week 42490648Jul. Modality analyses further suggested consistent benefit for exercise combined with cognitive training and for mind-body exercise within moderate dose ranges 42490648Jul.
In oncology, recent work has emphasized the feasibility and real-world implementation of personalized exercise programs during cancer treatment. The CHOiCE prospective study evaluated a flexible, patient-centered exercise program in routine clinical practice, reflecting ongoing efforts to translate the established benefits of exercise into pragmatic care across cancer types 42015889AprPMID 42101874. Related qualitative research has also examined barriers and facilitators to physical activity during surgical hospitalization for oral cancer, underscoring the importance of patient-centered approaches to early mobilization and adherence in the postoperative setting 42207318May. A broader review of cancer and depression also highlighted lifestyle factors, including exercise, as part of integrated therapeutic strategies for these co-occurring conditions 41672225Feb.
Exercise has also been studied in relation to cognitive and vascular outcomes. In vascular mild cognitive impairment, all participants receiving exercise therapy improved on executive-function measures over 6 months, and baseline frontal white matter hyperintensity burden appeared to influence cognitive response when exercise was combined with N-acetylcysteine versus placebo 41579736Jan. In stroke and transient ischemic attack populations, qualitative studies have explored barriers and facilitators to maintaining physical activity after mHealth interventions, reflecting interest in how exercise-related behavior change can be sustained after structured support ends 42202232May. Additional protocol-level work has described mobile health and prescription-based strategies intended to promote physical activity in people with cardiovascular risk factors, including children and individuals with type 1 diabetes, although these studies were focused on intervention design rather than outcomes 42172625May42009101Apr.
Cardiometabolic research continues to examine the optimal dose and type of exercise for adults with overweight or obesity, with a Bayesian model-based dose-response network meta-analysis protocol aiming to identify modality-dose combinations associated with favorable cardiometabolic profiles 42082211May. Observational work has also investigated associations between physical activity and cardiovascular-kidney-metabolic syndrome in older Chinese adults 42059054Apr. Finally, a review on healthy aging described exercise as one of several lifestyle factors linked to autophagy and the maintenance of healthspan, while noting that human evidence remains limited in some areas 41577121Jan.
What Changes, What Holds
1. Exercise now appears to have a dose window for mood benefit in Parkinson’s disease
NEW DIRECTION Exercise is already understood as a broad intervention for neurological and mental health outcomes, but this work narrows that picture by suggesting that antidepressant benefit in Parkinson’s disease is not simply “more is better.” The reported non-linear response, with a midrange sweet spot and weaker stability at very high dose, means dosing and modality may matter for clinical use 42490648Jul. The combined exercise-cognitive training and mind-body signals are promising but still need confirmation.
2. Cancer care is moving from efficacy claims toward implementation of exercise in routine treatment
REINFORCES The established account already treats exercise as a low-cost adjunct in oncology, and this paragraph strengthens that by showing the field is now focused on making it workable in real clinics rather than proving the concept again. The practical emphasis on personalization, postoperative mobilization, and integrated support does not change what exercise is for; it clarifies how it may be delivered and where adherence barriers remain 42015889Apr42207318May.
3. Exercise may improve executive function in vascular cognitive impairment, but response could depend on brain injury burden and add-on therapy
NEW DIRECTION Exercise is already linked to cognitive function in the baseline, yet this work adds a more specific and conditional role in vascular mild cognitive impairment. It suggests cognitive gains are not uniform and may vary with white matter disease burden and with whether exercise is paired with another intervention, which complicates any simple expectation of benefit 41579736Jan. The behavioral-maintenance studies in stroke/TIA are methodologically relevant but do not change the core claim.
4. The main question is no longer whether exercise helps cardiometabolic health, but which dose and modality best fit different risk profiles
REINFORCES The overview already frames exercise as a cardiometabolic intervention, and this paragraph mainly sharpens that established view by pushing the field toward optimization rather than discovery of a new role. Dose-response modeling in obesity, observational work in cardiovascular-kidney-metabolic syndrome, and healthy-aging/autophagy review material all sit comfortably inside the baseline account. What remains unsettled is comparative effectiveness across exercise types and whether proposed mechanisms translate cleanly into human outcomes 42082211May42059054Apr41577121Jan.
Overview update candidates: dose-dependent mood benefit in Parkinson’s disease; conditional cognitive response in vascular mild cognitive impairment; implementation-focused exercise delivery in cancer care.
exercise
Background Contexts
In the literature, the biological baseline, pathological conditions, or disease models commonly surrounding exercise are described as follows:
- arterial hypertension (Disease) — 2 papers: PMIDs 42082211, 42009101
- cardiovascular disease (Disease) — 2 papers: PMIDs 42082211, 42009101
- neoplasm (Disease) — 2 papers: PMIDs 42101874, 42015889
- obesity (Disease) — 2 papers: PMIDs 42082211, 42009101
- type 2 diabetes (Disease) — 2 papers: PMIDs 42101451, 42082211
- acetate (Chemical) — 1 paper: PMIDs 41672225
- Adolescents with visual impairment (Other) — 1 paper: PMIDs 42173929
- advanced cancer (Disease) — 1 paper: PMIDs 42053853
- Assays (Other) — 1 paper: PMIDs 41577121
- autophagy (Biological Process) — 1 paper: PMIDs 41577121
- cancer cachexia (Disease) — 1 paper: PMIDs 42053853
- Cardiovascular-Kidney-Metabolic syndrome (Disease) — 1 paper: PMIDs 42059054
Methodologies & Technologies Used
Researchers utilize the following experimental methods, imaging platforms, computational models, or biological reagents to study exercise:
- brain–computer interface (Technology) — 2 papers: PMIDs 42101451, 41928639
- CHOiCE (Choose Health: Oncological patients Centered Exercise) (Other) — 2 papers: PMIDs 42101874, 42015889
- 12 Kagetsu (Other) — 1 paper: PMIDs 42200312
- 24 months (Other) — 1 paper: PMIDs 42200312
- 6 months (Clinical Metric) — 1 paper: PMIDs 42200312
- Afterschool Rx program (Other) — 1 paper: PMIDs 42009101
- Age (Other) — 1 paper: PMIDs 42479776
- APA PsycINFO (Technology) — 1 paper: PMIDs 42490648
- Bayesian model-based dose-response network meta-analysis (Technology) — 1 paper: PMIDs 42082211
- Bayesian network meta-regression model (Technology) — 1 paper: PMIDs 42490648
- body mass index (Clinical Metric) — 1 paper: PMIDs 42479776
- clinical biochemical fasting samples (Other) — 1 paper: PMIDs 41928639
Molecular Interventions & Targets
The primary molecular pathways, regulatory genes, enzymes, or therapeutic agents actively targeted and manipulated in relation to exercise include:
- healthy diet (Biological Process) — 2 papers: PMIDs 42172625, 42009101
- aerobic cycling (Biological Process) — 1 paper: PMIDs 42490648
- Cardiometabolic health (Other) — 1 paper: PMIDs 42082211
- CD8+ S100B+ T cells (Cellular Component) — 1 paper: PMIDs 42213729
- depressive symptoms (Biological Process) — 1 paper: PMIDs 42490648
- diabetes (Disease) — 1 paper: PMIDs 41928639
- dietary restriction (Biological Process) — 1 paper: PMIDs 41577121
- Digit Symbol-Coding Test (Clinical Metric) — 1 paper: PMIDs 41579736
- ethanol (Chemical) — 1 paper: PMIDs 42172625
- exercise combined with cognitive training (Biological Process) — 1 paper: PMIDs 42490648
- functional training (Biological Process) — 1 paper: PMIDs 42490648
- Genetic perturbations (Other) — 1 paper: PMIDs 41577121
Observed Outcomes & Phenotypes
The phenotypic changes, physiological endpoints, or clinical metrics observed and measured in connection with exercise include:
- (chemo)radiotherapy (Biological Process) — 1 paper: PMIDs 42215482
- 1000 MET-minutes per week (Clinical Metric) — 1 paper: PMIDs 42490648
- 110-890 MET-minutes per week (Clinical Metric) — 1 paper: PMIDs 42490648
- 440-670 MET-minutes per week (Clinical Metric) — 1 paper: PMIDs 42490648
- 560 MET-minutes per week (Clinical Metric) — 1 paper: PMIDs 42490648
- 95% credible interval (Clinical Metric) — 1 paper: PMIDs 42490648
- Accuracy (Clinical Metric) — 1 paper: PMIDs 42479776
- anxiety disorders (Disease) — 1 paper: PMIDs 42215482
- arterial hypertension (Disease) — 1 paper: PMIDs 42215482
- AUC∞ (Clinical Metric) — 1 paper: PMIDs 42479776
- body fat percentage (Clinical Metric) — 1 paper: PMIDs 42101451
- Cardiovascular outcomes (Clinical Metric) — 1 paper: PMIDs 42009101
General Takeaways & Clinical Potentials
The high-level concepts, clinical translations, and overarching conclusions proposed in the research surrounding exercise are summarized below:
- class imbalance (Other) — 1 paper: PMIDs 42479776
- clinical translation (Other) — 1 paper: PMIDs 42479776
- collaboration with research users (Other) — 1 paper: PMIDs 42214066
- depression (Disease) — 1 paper: PMIDs 42490648
- greater autonomy in daily activities (Other) — 1 paper: PMIDs 42173929
- HealthSpan (Other) — 1 paper: PMIDs 41577121
- healthy aging (Other) — 1 paper: PMIDs 41577121
- healthy weight (Clinical Metric) — 1 paper: PMIDs 42215482
- hypocaloric diet (Therapy) — 1 paper: PMIDs 42101451
- Impact (Therapy) — 1 paper: PMIDs 42214066
- intermittent fasting combined with a ketogenic diet (Therapy) — 1 paper: PMIDs 42101451
- lifestyle interventions (Other) — 1 paper: PMIDs 42215482